Faizah Mohd Zaki MD, Presenter: Nothing to Disclose

Prakash Muthusami MBBS, MD, Abstract Co-Author: Nothing to Disclose

Suzanne Laughlin MD, Abstract Co-Author: Nothing to Disclose

Felix Ratjen, Abstract Co-Author: Nothing to Disclose

Helen Maree Branson MBBS, FRCR, Abstract Co-Author: Nothing to Disclose

At the end of this exhibit, learner will be able to: 1. describe the typical brain findings in Hereditary Hemorrhagic Telangiectasia among pediatric population based on the different types of cerebral arterio-venous malformation (CAVM). 2. explain the use of different imaging modalities in diagnosing CAVM and their utilization in the treatment management.  

1. The diagnostic criteria of HHT in pediatric population and the associated genetic mutation related to HHT. 2. The role of brain MRI screening in the detection of CAVM in HHT patients. 3. The types of CAVM that are found in HHT pediatric population ranging from developmental venous anomaly, cavernoma, arterial venous fistula and arteriovenous malformation, demonstrated by different imaging modalities including MRI, CT and angiography. 4. The intracranial complication of HHT depicted on neuroimaging.  

http://abstract.rsna.org/uploads/2014/14006169/14006169_iekr.pdf

Mohd Zaki, F, Muthusami, P, Laughlin, S, Ratjen, F, Branson, H, Neuroimaging Findings in Pediatric Patients with Hereditary Hemorrhagic Telangiectasia.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14006169.html